BioCryst Pharmaceuticals

From WikiMD.org
Jump to navigation Jump to search

BioCryst Pharmaceuticals

BioCryst Pharmaceuticals (pronunciation: /ˈbaɪoʊˌkrɪst fɑːrˈmæsjuːtɪkəlz/) is an American biotechnology company that specializes in the research and development of novel small-molecule drugs. The company was founded in 1986 and is headquartered in Durham, North Carolina.

Etymology

The name "BioCryst" is derived from the company's focus on crystallography, a method used in the study of biological structures and a key component in the company's drug discovery process.

Operations

BioCryst Pharmaceuticals' primary focus is on the development of new treatments for rare and infectious diseases. The company uses structure-guided drug design, which involves the use of X-ray crystallography to visualize the three-dimensional atomic structure of a molecule, to develop new therapeutic agents.

The company's portfolio includes approved drugs such as Rapivab, a treatment for influenza, and Orladeyo, a treatment for hereditary angioedema. It also has several drugs in development, including BCX9930, an oral Factor D inhibitor for the treatment of complement-mediated diseases.

Related Terms

  • Biotechnology: The use of living systems and organisms to develop or make products.
  • Crystallography: The science that examines the arrangement of atoms in solids.
  • X-ray crystallography: A technique used for determining the atomic and molecular structure of a crystal.
  • Rapivab: An antiviral drug for treatment of early onset influenza.
  • Orladeyo: A drug used for prophylaxis to prevent attacks of hereditary angioedema (HAE).
  • BCX9930: An investigational drug being developed by BioCryst Pharmaceuticals.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski